Resources
Full-Service CRO Overview
We are pleased to share Dr. Vince Clinical Research’s latest brochure, providing an in-depth overview of our full-service CRO solutions.
Effective Study Design and Execution of Renal and Hepatic Impairment Trials
As most medications are primarily excreted through the kidneys or liver, most drugs in development will require a renal ...
How Including Cognition as a Safety Endpoint Provides a Competitive Differentiator
In today’s rapidly evolving pharmaceutical landscape, cognitive safety is emerging as a critical factor that can set ...
From Chance Discovery to Molecular Biology
Dr. Sheldon H. Preskorn's presentation, "From Chance Discovery to Molecular Biology," highlights the evolution of ...
Innovation in a First-In-Human Trial
With over 70,000 annual deaths, fentanyl overdose is the leading cause of death for Americans aged 18-45. In collaboration ...
Renal and Hepatic Impairment Studies
Dr. Vince Clinical Research (DVCR) specializes in evaluating the effects of renal and hepatic impairments on drug ...
Accelerating Clinical & Drug Development Timelines with AI
As the drug development landscape rapidly evolves, artificial intelligence (AI) is emerging as a transformative force, ...
Primary and Secondary Outcomes From a Phase I Study Comparing the Respiratory Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration
Lynn Webster, MD, Executive Vice President of Scientific Affairs, recently presented his poster titled “A Review of the ...
Opioid Abuse-Deterrent Formulations: Impact and Barriers to Access
Our Executive Vice President of Scientific Affairs, Dr. Lynn Webster, has released a co-authored review on opioid ...
Establishing Early Efficacy in Depression Clinical Trials
This article is featured on The Association of Clinical Research Professionals (ACRP). Bradley D. Vince, DO and Sheldon H. ...
Updates on Human Abuse Potential Studies: Challenges and Regulatory Guidelines
Discover this groundbreaking webinar delving into the latest insights from the CCALC and the FDA in drug development and clinical evaluation of human drug abuse and dependence potential.
3 Essential Components of Successful Renal and Hepatic Impairment Studies
Most drugs are eliminated from the body through some combination of vital organs, such as the small intestine, liver and/or ...